2023
Dehinsilu, J., Sergaki, C., Amos, G., Fontana, V., & Pirmohamed, M. (n.d.). The interplay between the microbiome and colonic immune system in checkpoint inhibitor therapy. Frontiers in Microbiomes, 2. doi:10.3389/frmbi.2023.1061193DOI: 10.3389/frmbi.2023.1061193
Swen, J. J., van der Wouden, C. H., Manson, L. E., Abdullah-Koolmees, H., Blagec, K., Blagus, T., . . . Ubiquitous Pharmacogenomics Consortium. (2023). A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study.. Lancet (London, England), 401(10374), 347-356. doi:10.1016/s0140-6736(22)01841-4DOI: 10.1016/s0140-6736(22)01841-4
2022
Fontana, V., Turner, R. M., Francis, B., Yin, P., Puetz, B., Hiltunen, T. P., . . . Pirmohamed, M. (2022). Chromosomal Region 11p14.1 is Associated with Pharmacokinetics and Pharmacodynamics of Bisoprolol. PHARMACOGENOMICS & PERSONALIZED MEDICINE, 15, 249-260. doi:10.2147/PGPM.S352719DOI: 10.2147/PGPM.S352719
Transcriptome During Normal Cell Differentiation (Chapter)
Bombonato-Prado, K. F., Rosa, A. L., de Oliveira, P. T., Dernowsek, J. A., Fontana, V., Evangelista, A. F., & Passos, G. A. (2022). Transcriptome During Normal Cell Differentiation. In Transcriptomics in Health and Disease (pp. 209-222). Springer International Publishing. doi:10.1007/978-3-030-87821-4_9DOI: 10.1007/978-3-030-87821-4_9
2020
Turner, R. M., de Koning, E. M., Fontana, V., Thompson, A., & Pirmohamed, M. (2020). Multimorbidity, polypharmacy, and drug-drug-gene interactions following a non-ST elevation acute coronary syndrome: analysis of a multicentre observational study. BMC MEDICINE, 18(1). doi:10.1186/s12916-020-01827-zDOI: 10.1186/s12916-020-01827-z
Turner, R. M., Fontana, V., Zhang, J. E., Carr, D., Yin, P., FitzGerald, R., . . . Pirmohamed, M. (2020). A Genome‐wide Association Study of Circulating Levels of Atorvastatin and Its Major Metabolites. Clinical Pharmacology and Therapeutics, 108(2), 287-297. doi:10.1002/cpt.1820DOI: 10.1002/cpt.1820
Alcantara, L. M., Ferreira, T. C. S., Fontana, V., Chatelain, E., Moraes, C. B., & Freitas-Junior, L. H. (2020). A Multi-Species Phenotypic Screening Assay for Leishmaniasis Drug Discovery Shows That Active Compounds Display a High Degree of Species-Specificity. MOLECULES, 25(11). doi:10.3390/molecules25112551DOI: 10.3390/molecules25112551
Turner, R. M., Fontana, V., FitzGerald, R., Morris, A. P., & Pirmohamed, M. (2020). Investigating the clinical factors and comedications associated with circulating levels of atorvastatin and its major metabolites in secondary prevention. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 86(1), 62-74. doi:10.1111/bcp.14133DOI: 10.1111/bcp.14133
2019
CD8+Tcell integrin α4β7expression: a potential predictor of severity and steroid sensitivity in checkpoint inhibitor induced colitis (Conference Paper)
Olsson-Brown, A., Sacco, J., Olsson-Brown, A., Olsson-Brown, A., Cachinho, S., Jolly, C., . . . Pirmohamed, M. (2019). CD8+Tcell integrin α4β7expression: a potential predictor of severity and steroid sensitivity in checkpoint inhibitor induced colitis. In JOURNAL FOR IMMUNOTHERAPY OF CANCER Vol. 7. Retrieved from https://www.webofscience.com/
2018
Turner, R. M., Fontana, V., Bayliss, M., Whalley, S., Castelazo, A. S., & Pirmohamed, M. (2018). Development, validation and application of a novel HPLC-MS/MS method for the quantification of atorvastatin, bisoprolol and clopidogrel in a large cardiovascular patient cohort. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 159, 272-281. doi:10.1016/j.jpba.2018.06.062DOI: 10.1016/j.jpba.2018.06.062
2017
Parreira, R. C., Guimaraes Lacerda, L. H., Vasconcellos, R., Lima, S. S., Santos, A. K., Fontana, V., . . . Resende, R. R. (2017). Decoding resistant hypertension signalling pathways. CLINICAL SCIENCE, 131(23), 2813-2834. doi:10.1042/CS20171398DOI: 10.1042/CS20171398
Linciano, P., Dawson, A., Poehner, I., Costa, D. M., Sa, M. S., Cordeiro-da-Silva, A., . . . Costi, M. P. (2017). Exploiting the 2-Amino-1,3,4-thiadiazole Scaffold To Inhibit <i>Trypanosoma brucei</i> Pteridine Reductase in Support of Early-Stage Drug Discovery. ACS OMEGA, 2(9), 5666-5683. doi:10.1021/acsomega.7b00473DOI: 10.1021/acsomega.7b00473
Sabbatini, A. R., Barbaro, N. R., de Faria, A. P., Ritter, A. M. V., Modolo, R., Correa, N. B., . . . Moreno, H. (2017). Matrix metalloproteinase-2-735C/T polymorphism is associated with resistant hypertension in a specialized outpatient clinic in Brazil. GENE, 620, 23-29. doi:10.1016/j.gene.2017.04.004DOI: 10.1016/j.gene.2017.04.004
Di Pisa, F., Landi, G., Dello Iacono, L., Pozzi, C., Borsari, C., Ferrari, S., . . . Mangani, S. (2017). Chroman-4-One Derivatives Targeting Pteridine Reductase 1 and Showing Anti-Parasitic Activity. MOLECULES, 22(3). doi:10.3390/molecules22030426DOI: 10.3390/molecules22030426
Oliveira-Paula, G. H., Luizon, M. R., Lacchini, R., Fontana, V., Silva, P. S., Biagi, C., & Tanus-Santos, J. E. (2017). Gene–Gene Interactions Among PRKCA, NOS3 and BDKRB2 Polymorphisms Affect the Antihypertensive Effects of Enalapril. Basic and Clinical Pharmacology and Toxicology, 120(3), 284-291. doi:10.1111/bcpt.12682DOI: 10.1111/bcpt.12682
Methoxylated 2′-hydroxychalcones as antiparasitic hit compounds (Journal article)
Borsari, C., Santarem, N., Torrado, J., Olias, A. I., Corral, M. J., Baptista, C., . . . Costi, M. P. (2017). Methoxylated 2′-hydroxychalcones as antiparasitic hit compounds. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 126, 1129-1135. doi:10.1016/j.ejmech.2016.12.017DOI: 10.1016/j.ejmech.2016.12.017
2016
Sabbatini, A. R., Barbaro, N. R., de Faria, A. P., Modolo, R., Ritter, A. M. V., Pinho, C., . . . Moreno, H. (2016). Increased Circulating Tissue Inhibitor of Metalloproteinase-2 Is Associated With Resistant Hypertension. JOURNAL OF CLINICAL HYPERTENSION, 18(10), 969-975. doi:10.1111/jch.12865DOI: 10.1111/jch.12865
ALTERATIONS IN METALLOPROTEINASE 9 AND TISSUE INHIBITOR 1 LEVELS IN RESISTANT HYPERTENSION AND THEIR RELATIONSHIP TO LEFT VENTRICULAR HYPERTROPHY (Conference Paper)
Barbaro, N., Sabbatini, A., Ritter, A., Almeida, A., Faria, A., Brunelli, V., . . . Moreno, H. (2016). ALTERATIONS IN METALLOPROTEINASE 9 AND TISSUE INHIBITOR 1 LEVELS IN RESISTANT HYPERTENSION AND THEIR RELATIONSHIP TO LEFT VENTRICULAR HYPERTROPHY. In JOURNAL OF HYPERTENSION Vol. 34 (pp. E171). doi:10.1097/01.hjh.0000491809.96475.a2DOI: 10.1097/01.hjh.0000491809.96475.a2
MATRIX METALLOPROTEINASE 2 GENE POLYMORPHISM ASSOCIATES WITH RESISTANT HYPERTENSION (Conference Paper)
Sabbatini, A., De Faria, A. P., Ruggeri, N., Modolo, R., Ritter, A., Batista, N., . . . Moreno Junior, H. (2016). MATRIX METALLOPROTEINASE 2 GENE POLYMORPHISM ASSOCIATES WITH RESISTANT HYPERTENSION. In JOURNAL OF HYPERTENSION Vol. 34 (pp. E257). doi:10.1097/01.hjh.0000492082.48991.8cDOI: 10.1097/01.hjh.0000492082.48991.8c
Endothelial nitric oxide synthase tagSNPs influence the effects of enalapril in essential hypertension (Journal article)
Oliveira-Paula, G. H., Lacchini, R., Luizon, M. R., Fontana, V., Silva, P. S., Biagi, C., & Tanus-Santos, J. E. (2016). Endothelial nitric oxide synthase tagSNPs influence the effects of enalapril in essential hypertension. NITRIC OXIDE-BIOLOGY AND CHEMISTRY, 55-56, 62-69. doi:10.1016/j.niox.2016.03.006DOI: 10.1016/j.niox.2016.03.006
Association of Mineralocorticoid Receptor Polymorphism I180V With Left Ventricular Hypertrophy in Resistant Hypertension (Journal article)
Versuti Ritter, A. M., Fontana, V., Cabral de Faria, A. P., Modolo, R., Barbaro, N. R., Sabbatini, A. R., . . . Moreno, H. (2016). Association of Mineralocorticoid Receptor Polymorphism I180V With Left Ventricular Hypertrophy in Resistant Hypertension. AMERICAN JOURNAL OF HYPERTENSION, 29(2), 245-250. doi:10.1093/ajh/hpv070DOI: 10.1093/ajh/hpv070
Does Renal Denervation Fit All Resistant Hypertension? The Role of Genetics (Journal article)
Ritter, A. M. V., de Faria, A. P., Fontana, V., Modolo, R., & Moreno, H. (2016). Does Renal Denervation Fit All Resistant Hypertension? The Role of Genetics. JOURNAL OF CLINICAL HYPERTENSION, 18(2), 161-162. doi:10.1111/jch.12642DOI: 10.1111/jch.12642
2015
Polymorphisms in <i>VEGFA</i> gene affect the antihypertensive responses to enalapril (Journal article)
Oliveira-Paula, G. H., Lacchini, R., Fontana, V., Silva, P. S., Biagi, C., & Tanus-Santos, J. E. (2015). Polymorphisms in <i>VEGFA</i> gene affect the antihypertensive responses to enalapril. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 71(8), 949-957. doi:10.1007/s00228-015-1872-5DOI: 10.1007/s00228-015-1872-5
Role Of MMP-2 and MMP-9 in Resistance to Drug Therapy in Patients with Resistant Hypertension (Journal article)
Lacerda, L., de Faria, A. P., Fontana, V., Moreno, H., & Sandrim, V. (2015). Role Of MMP-2 and MMP-9 in Resistance to Drug Therapy in Patients with Resistant Hypertension. ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 105(2), 168-174. doi:10.5935/abc.20150060DOI: 10.5935/abc.20150060
Adiponectin-11377C/G and+276G/T Polymorphisms affect Adiponectin Levels but do not Modify Responsiveness to Therapy in Resistant Hypertension (Journal article)
de Faria, A. P. C., Modolo, R., Sabbatini, A. R., Barbaro, N. R., Correa, N. B., Brunelli, V., . . . Moreno, H. (2015). Adiponectin-11377C/G and+276G/T Polymorphisms affect Adiponectin Levels but do not Modify Responsiveness to Therapy in Resistant Hypertension. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 117(1), 65-72. doi:10.1111/bcpt.12368DOI: 10.1111/bcpt.12368
An update on the pharmacogenetics of treating hypertension (Journal article)
Fontana, V., Luizon, M. R., & Sandrim, V. C. (2015). An update on the pharmacogenetics of treating hypertension. JOURNAL OF HUMAN HYPERTENSION, 29(5), 283-291. doi:10.1038/jhh.2014.76DOI: 10.1038/jhh.2014.76
An update on the role of adipokines in arterial stiffness and hypertension (Journal article)
Sabbatini, A. R., Fontana, V., Laurent, S., & Moreno, H. (2015). An update on the role of adipokines in arterial stiffness and hypertension. JOURNAL OF HYPERTENSION, 33(3), 435-444. doi:10.1097/HJH.0000000000000444DOI: 10.1097/HJH.0000000000000444
Predictors of Silent Myocardial Ischemia in Resistant Hypertensive Patients (Journal article)
Modolo, R., de Faria, A. P., Paganelli, M. O., Sabbatini, A. R., Barbaro, N. R., Nascimento, B. B., . . . Moreno, H. (2015). Predictors of Silent Myocardial Ischemia in Resistant Hypertensive Patients. AMERICAN JOURNAL OF HYPERTENSION, 28(2), 200-207. doi:10.1093/ajh/hpu140DOI: 10.1093/ajh/hpu140
Increased arterial stiffness in resistant hypertension is associated with inflammatory biomarkers (Journal article)
Barbaro, N. R., Fontana, V., Modolo, R., De Faria, A. P., Sabbatini, A. R., Fonseca, F. H., . . . Moreno, H. (2015). Increased arterial stiffness in resistant hypertension is associated with inflammatory biomarkers. BLOOD PRESSURE, 24(1), 7-13. doi:10.3109/08037051.2014.940710DOI: 10.3109/08037051.2014.940710
Vascular Damage in Resistant Hypertension: TNF-Alpha Inhibition Effects on Endothelial Cells (Journal article)
Barbaro, N. R., de Araujo, T. M., Tanus-Santos, J. E., Anhe, G. F., Fontana, V., & Moreno, H. (2015). Vascular Damage in Resistant Hypertension: TNF-Alpha Inhibition Effects on Endothelial Cells. BIOMED RESEARCH INTERNATIONAL, 2015. doi:10.1155/2015/631594DOI: 10.1155/2015/631594
2014
Large-Scale Gene-Centric Analysis Identifies Polymorphisms for Resistant Hypertension (Journal article)
Fontana, V., McDonough, C. W., Gong, Y., El Rouby, N. M., Sa, A. C. C., Taylor, K. D., . . . Cooper-DeHoff, R. M. (2014). Large-Scale Gene-Centric Analysis Identifies Polymorphisms for Resistant Hypertension. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 3(6). doi:10.1161/JAHA.114.001398DOI: 10.1161/JAHA.114.001398
Adipokines: Novel Players in Resistant Hypertension (Journal article)
de Faria, A. P., Modolo, R., Fontana, V., & Moreno, H. (2014). Adipokines: Novel Players in Resistant Hypertension. JOURNAL OF CLINICAL HYPERTENSION, 16(10), 754-759. doi:10.1111/jch.12399DOI: 10.1111/jch.12399
DC isoketal-modified proteins activate T cells and promote hypertension (Journal article)
Kirabo, A., Fontana, V., de Faria, A. P. C., Loperena, R., Galindo, C. L., Wu, J., . . . Harrison, D. G. (2014). DC isoketal-modified proteins activate T cells and promote hypertension. JOURNAL OF CLINICAL INVESTIGATION, 124(10), 4642-4656. doi:10.1172/JCI74084DOI: 10.1172/JCI74084
The white-coat effect is an independent predictor of myocardial ischemia in resistant hypertension (Journal article)
Modolo, R., Barbaro, N. R., de Faria, A. P., Sabbatini, A. R., Paganelli, M. O., Fontana, V., & Moreno, H. (2014). The white-coat effect is an independent predictor of myocardial ischemia in resistant hypertension. BLOOD PRESSURE, 23(5), 276-280. doi:10.3109/08037051.2014.883194DOI: 10.3109/08037051.2014.883194
Plasma 8-isoprostane levels are associated with endothelial dysfunction in resistant hypertension (Journal article)
Cabral de Faria, A. P., Fontana, V., Modolo, R., Barbaro, N. R., Sabbatini, A. R., Pansani, I. F., . . . Moreno, H. (2014). Plasma 8-isoprostane levels are associated with endothelial dysfunction in resistant hypertension. CLINICA CHIMICA ACTA, 433, 179-183. doi:10.1016/j.cca.2014.03.009DOI: 10.1016/j.cca.2014.03.009
Tadalafil-induced improvement in left ventricular diastolic function in resistant hypertension (Journal article)
Santos, R. C., de Faria, A. P. C., Barbaro, N. R., Modolo, R., Ferreira-Melo, S. E., Matos-Souza, J. R., . . . Moreno, H. (2014). Tadalafil-induced improvement in left ventricular diastolic function in resistant hypertension. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 70(2), 147-154. doi:10.1007/s00228-013-1611-8DOI: 10.1007/s00228-013-1611-8
ATP2B1 LOCUS IS ASSOCIATED WITH RESISTANT HYPERTENSION IN THE INTERNATIONAL VERAPAMIL SR TANDOLAPRIL STUDY-GENETIC SUBSTUDY (INVESTGENES) (Conference Paper)
Fontana, V., McDonough, C. W., Gong, Y., El Rouby, N. M., Sa, A. C., Pepine, C. J., . . . Johnson, J. A. (2014). ATP2B1 LOCUS IS ASSOCIATED WITH RESISTANT HYPERTENSION IN THE INTERNATIONAL VERAPAMIL SR TANDOLAPRIL STUDY-GENETIC SUBSTUDY (INVESTGENES). In CLINICAL PHARMACOLOGY & THERAPEUTICS Vol. 95 (pp. S26-S27). Retrieved from https://www.webofscience.com/
Barbaro, N. R., Fontana, V., & Moreno, H. (2014). Angiotensinogen Variants among Resistant Hypertensive Patients.. International journal of hypertension, 2014, 424793. doi:10.1155/2014/424793DOI: 10.1155/2014/424793
Dendritic cell superoxide and isoketals activate T cells and promote angiotensin II hypertension (Conference Paper)
Kirabo, A., Fontana, V., Davies, S., Roberts, L. J., de Faria, A., Galindo, C., . . . Harrison, D. (2014). Dendritic cell superoxide and isoketals activate T cells and promote angiotensin II hypertension. In FASEB JOURNAL Vol. 28. Retrieved from https://www.webofscience.com/
Deregulation of adipokines related to target organ damage on resistant hypertension (Journal article)
Sabbatini, A. R., Faria, A. P., Barbaro, N. R., Gordo, W. M., Modolo, R. G. P., Pinho, C., . . . Moreno, H. (2014). Deregulation of adipokines related to target organ damage on resistant hypertension. JOURNAL OF HUMAN HYPERTENSION, 28(6), 388-392. doi:10.1038/jhh.2013.118DOI: 10.1038/jhh.2013.118
Effects of Angiotensin-Converting Enzyme Inhibition on Leptin and Adiponectin Levels in Essential Hypertension (Journal article)
Fontana, V., Cabral de Faria, A. P., Oliveira-Paula, G. H., Silva, P. S., Biagi, C., Tanus-Santos, J. E., & Moreno, H. (2014). Effects of Angiotensin-Converting Enzyme Inhibition on Leptin and Adiponectin Levels in Essential Hypertension. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 114(6), 472-475. doi:10.1111/bcpt.12195DOI: 10.1111/bcpt.12195
Modulation of aldosterone levels by-344 C/T <i>CYP11B2</i> polymorphism and spironolactone use in resistant hypertension (Journal article)
Fontana, V., Cabral de Faria, A. P., Barbaro, N. R., Sabbatini, A. R., Modolo, R., Lacchini, R., & Moreno, H. (2014). Modulation of aldosterone levels by-344 C/T <i>CYP11B2</i> polymorphism and spironolactone use in resistant hypertension. JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION, 8(3), 146-151. doi:10.1016/j.jash.2013.12.001DOI: 10.1016/j.jash.2013.12.001
Relationship of left ventricular hypertrophy, age, and renal artery stenosis (Journal article)
Barbaro, N. R., Fontana, V., & Moreno, H. (2014). Relationship of left ventricular hypertrophy, age, and renal artery stenosis. JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION, 8(5), 360. doi:10.1016/j.jash.2014.02.007DOI: 10.1016/j.jash.2014.02.007
2013
Acute cardiac and hemodynamic effects of sildenafil on resistant hypertension (Journal article)
Quinaglia, T., de Faria, A. P. C., Fontana, V., Barbaro, N. R., Sabbatini, A. R., Sertorio, J. T., . . . Moreno, H. (2013). Acute cardiac and hemodynamic effects of sildenafil on resistant hypertension. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 69(12), 2027-2036. doi:10.1007/s00228-013-1571-zDOI: 10.1007/s00228-013-1571-z
Hypoadiponectinemia and aldosterone excess are associated with lack of blood pressure control in subjects with resistant hypertension (Journal article)
de Faria, A. P. C., Demacq, C., Figueiredo, V. N., Moraes, C. H., Santos, R. C., Sabbatini, A. R., . . . Moreno, H. J. (2013). Hypoadiponectinemia and aldosterone excess are associated with lack of blood pressure control in subjects with resistant hypertension. HYPERTENSION RESEARCH, 36(12), 1067-1072. doi:10.1038/hr.2013.92DOI: 10.1038/hr.2013.92
<i>eNOS</i> and <i>BDKRB2</i> genotypes affect the antihypertensive responses to enalapril (Journal article)
Silva, P. S., Fontana, V., Luizon, M. R., Lacchini, R., Silva, W. A. J., Biagi, C., & Tanus-Santos, J. E. (2013). <i>eNOS</i> and <i>BDKRB2</i> genotypes affect the antihypertensive responses to enalapril. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 69(2), 167-177. doi:10.1007/s00228-012-1326-2DOI: 10.1007/s00228-012-1326-2
Glycated Hemoglobin Levels Predict Arterial Stiffness nad Endothelial Dysfunction in Resistant Hypertensive Diabetic Subjects (Conference Paper)
Moreno, B. M., Modolo, R., Faria, A. P., Barbaro, N., Sabbatini, A., Pansani, I., . . . Moreno, H. M. J. (2013). Glycated Hemoglobin Levels Predict Arterial Stiffness nad Endothelial Dysfunction in Resistant Hypertensive Diabetic Subjects. In HYPERTENSION Vol. 62. Retrieved from https://www.webofscience.com/
UNCONTROLLED RESISTANT HYPERTENSION IS ACCOMPANIED BY DECREASED LEVELS OF ADIPONECTIN COMPARED TO CONTROLLED RESISTANT HYPERTENSION (Conference Paper)
Fontana, V., Faria, A. C., Santos, R. C., Sabbatini, A. R., Barbaro, N. R., Modolo, R. G., . . . Moreno, H. J. (2013). UNCONTROLLED RESISTANT HYPERTENSION IS ACCOMPANIED BY DECREASED LEVELS OF ADIPONECTIN COMPARED TO CONTROLLED RESISTANT HYPERTENSION. In CLINICAL PHARMACOLOGY & THERAPEUTICS Vol. 93 (pp. S87-S88). Retrieved from https://www.webofscience.com/
2012
Comprehensive Evaluation of the Effects of Enalapril on Matrix Metalloproteinases Levels in Hypertension (Journal article)
Fontana, V., Silva, P. S., Izidoro-Toledo, T. C., Biagi, C., Oliveira, E. B., Gerlach, R. F., & Tanus-Santos, J. E. (2012). Comprehensive Evaluation of the Effects of Enalapril on Matrix Metalloproteinases Levels in Hypertension. CARDIOVASCULAR DRUGS AND THERAPY, 26(6), 511-519. doi:10.1007/s10557-012-6420-2DOI: 10.1007/s10557-012-6420-2
Specific matrix metalloproteinase 9 (MMP-9) haplotype affect the circulating MMP-9 levels in women with migraine (Journal article)
Martins-Oliveira, A., Goncalves, F. M., Speciali, J. G., Fontana, V., Izidoro-Toledo, T. C., Belo, V. A., . . . Tanus-Santos, J. E. (2012). Specific matrix metalloproteinase 9 (MMP-9) haplotype affect the circulating MMP-9 levels in women with migraine. JOURNAL OF NEUROIMMUNOLOGY, 252(1-2), 89-94. doi:10.1016/j.jneuroim.2012.07.016DOI: 10.1016/j.jneuroim.2012.07.016
Circulating matrix metalloproteinases and their inhibitors in hypertension (Journal article)
Fontana, V., Silva, P. S., Gerlach, R. F., & Tanus-Santos, J. E. (2012). Circulating matrix metalloproteinases and their inhibitors in hypertension. CLINICA CHIMICA ACTA, 413(7-8), 656-662. doi:10.1016/j.cca.2011.12.021DOI: 10.1016/j.cca.2011.12.021
Differential Gene Expression Profiles May Differentiate Responder and Nonresponder Patients with Rheumatoid Arthritis for Methotrexate (MTX) Monotherapy and MTX plus Tumor Necrosis Factor Inhibitor Combined Therapy (Journal article)
Ribeiro Oliveira, R. D., Fontana, V., Junta, C. M., Chiquitelli Marques, M. M., Macedo, C., Rassi, D. M., . . . Louzada-Junior, P. (2012). Differential Gene Expression Profiles May Differentiate Responder and Nonresponder Patients with Rheumatoid Arthritis for Methotrexate (MTX) Monotherapy and MTX plus Tumor Necrosis Factor Inhibitor Combined Therapy. JOURNAL OF RHEUMATOLOGY, 39(8), 1524-1532. doi:10.3899/jrheum.120092DOI: 10.3899/jrheum.120092
True Prevalence of Resistant Hypertension (Journal article)
Sabbatini, A. R., Fontana, V., & Moreno, H. J. (2012). True Prevalence of Resistant Hypertension. ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 99(5), 1068. doi:10.1590/S0066-782X2012001400014DOI: 10.1590/S0066-782X2012001400014
2011
Consistent Alterations of Circulating Matrix Metalloproteinases Levels in Untreated Hypertensives and in Spontaneously Hypertensive Rats: A Relevant Pharmacological Target (Journal article)
Fontana, V., Silva, P. S., Belo, V. A., Antonio, R. C., Ceron, C. S., Biagi, C., . . . Tanus-Santos, J. E. (2011). Consistent Alterations of Circulating Matrix Metalloproteinases Levels in Untreated Hypertensives and in Spontaneously Hypertensive Rats: A Relevant Pharmacological Target. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 109(2), 130-137. doi:10.1111/j.1742-7843.2011.00698.xDOI: 10.1111/j.1742-7843.2011.00698.x
Antihypertensive effects exerted by enalapril in mild to moderate hypertension are not associated with changes in the circulating levels of nitric oxide-related markers (Journal article)
Silva, P. S., Fontana, V., Palei, A. C. T., Sertorio, J. T. C., Biagi, C., & Tanus-Santos, J. E. (2011). Antihypertensive effects exerted by enalapril in mild to moderate hypertension are not associated with changes in the circulating levels of nitric oxide-related markers. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 67(4), 365-370. doi:10.1007/s00228-011-1003-xDOI: 10.1007/s00228-011-1003-x
Differences in Gene Expression Profiles in Rheumatoid Arthritis Peripheral Blood Mononuclear Cells Suggest Apoptosis As Relevant Mechanism for Response to Methotrexate Monotherapy (Conference Paper)
Oliveira, R. D., Fontana, V., Macedo, C., Junta, C. M., Donadi, E. A., Passos, G. A., & Louzada-Junior, P. (2011). Differences in Gene Expression Profiles in Rheumatoid Arthritis Peripheral Blood Mononuclear Cells Suggest Apoptosis As Relevant Mechanism for Response to Methotrexate Monotherapy. In ARTHRITIS AND RHEUMATISM Vol. 63 (pp. S485). Retrieved from https://www.webofscience.com/
2010
Spironolactone and hydrochlorothiazide exert antioxidant effects and reduce vascular matrix metalloproteinase-2 activity and expression in a model of renovascular hypertension (Journal article)
Ceron, C. S., Castro, M. M., Rizzi, E., Montenegro, M. F., Fontana, V., Salgado, M. C. O., . . . Tanus-Santos, J. E. (2010). Spironolactone and hydrochlorothiazide exert antioxidant effects and reduce vascular matrix metalloproteinase-2 activity and expression in a model of renovascular hypertension. BRITISH JOURNAL OF PHARMACOLOGY, 160(1), 77-87. doi:10.1111/j.1476-5381.2010.00678.xDOI: 10.1111/j.1476-5381.2010.00678.x
2009
Comparative expression and transcriptional networks of human-mouse syntenic genes during osteoblastic differentiation of bone marrow mesenchymal stem cells (Conference Paper)
Dernowsek, J. A., Fontana, V., Evangelista, A. F., Junta, C. M., Marques, M. M. C., Macedo, C., . . . Passos, G. A. S. (2009). Comparative expression and transcriptional networks of human-mouse syntenic genes during osteoblastic differentiation of bone marrow mesenchymal stem cells. In FASEB JOURNAL Vol. 23. Retrieved from https://www.webofscience.com/
